Birdwatch Note
2023-09-15 12:21:34 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
La FDA n'a pas été condamnée, la plainte a été reconduit sur un autre système judiciaire (5th Circuit Appeals Court). De plus la FDA n'autorise toujours pas l'Ivermectine et poursuit sa contre indication. https://thehill.com/regulation/court-battles/4184259-federal-appeals-court-revives-lawsuit-against-fda-over-covid-19-ivermectin-messaging/ https://www.reuters.com/article/factcheck-fda-ivermectin-covid-idUSL1N3AB1PS
Written by D272796145488D5D9CA98865128916AEBF575BCABB2AA35BF5CEEA413BF5F1F3
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1702374672820506970
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1702658915568177303
- noteId - 1702658915568177303
- participantId -
- noteAuthorParticipantId - D272796145488D5D9CA98865128916AEBF575BCABB2AA35BF5CEEA413BF5F1F3 Participant Details
- createdAtMillis - 1694780494003
- tweetId - 1702374672820506970
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- La FDA n'a pas été condamnée, la plainte a été reconduit sur un autre système judiciaire (5th Circuit Appeals Court). De plus la FDA n'autorise toujours pas l'Ivermectine et poursuit sa contre indication. https://thehill.com/regulation/court-battles/4184259-federal-appeals-court-revives-lawsuit-against-fda-over-covid-19-ivermectin-messaging/ https://www.reuters.com/article/factcheck-fda-ivermectin-covid-idUSL1N3AB1PS
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2023-09-15 12:21:34 UTC (1694780494003) |
1969-12-31 23:59:59 UTC (-1) |
2023-09-16 02:12:36 UTC (1694830356504) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
Note Ratings
| rated at | rated by | |
| 2023-09-15 17:16:41 -0500 | Rating Details | |
| 2023-09-15 15:53:17 -0500 | Rating Details | |
| 2023-09-15 13:33:20 -0500 | Rating Details | |
| 2023-09-15 13:16:13 -0500 | Rating Details | |
| 2023-09-15 12:57:45 -0500 | Rating Details | |
| 2023-09-15 12:35:28 -0500 | Rating Details | |
| 2023-09-15 11:26:31 -0500 | Rating Details | |
| 2023-09-15 11:08:22 -0500 | Rating Details | |
| 2023-09-15 10:47:23 -0500 | Rating Details | |
| 2023-09-15 09:49:38 -0500 | Rating Details | |
| 2023-09-15 09:45:03 -0500 | Rating Details | |
| 2023-09-15 08:51:12 -0500 | Rating Details | |
| 2023-09-15 08:27:19 -0500 | Rating Details | |
| 2023-09-15 08:22:13 -0500 | Rating Details | |
| 2023-09-15 08:13:25 -0500 | Rating Details | |
| 2023-09-15 07:37:24 -0500 | Rating Details | |
| 2023-09-16 15:35:37 -0500 | Rating Details | |
| 2023-09-16 14:24:23 -0500 | Rating Details | |
| 2023-09-16 12:06:20 -0500 | Rating Details | |
| 2023-09-16 08:10:10 -0500 | Rating Details | |
| 2023-09-16 07:12:24 -0500 | Rating Details | |
| 2023-09-16 05:45:02 -0500 | Rating Details | |
| 2023-09-16 04:21:57 -0500 | Rating Details | |
| 2023-09-16 00:55:42 -0500 | Rating Details | |
| 2023-09-15 21:47:58 -0500 | Rating Details | |
| 2023-09-15 21:30:36 -0500 | Rating Details | |
| 2023-09-17 07:11:31 -0500 | Rating Details | |
| 2023-09-17 02:48:57 -0500 | Rating Details | |
| 2023-09-17 00:32:42 -0500 | Rating Details | |
| 2023-09-25 10:11:17 -0500 | Rating Details | |
| 2023-10-02 10:29:10 -0500 | Rating Details | |
| 2023-10-23 16:19:29 -0500 | Rating Details | |
| 2023-10-31 10:21:49 -0500 | Rating Details | |
| 2023-10-29 19:10:19 -0500 | Rating Details | |
| 2023-11-06 14:20:37 -0600 | Rating Details | |
| 2023-11-15 11:24:04 -0600 | Rating Details | |
| 2024-01-21 11:01:37 -0600 | Rating Details | |
| 2024-01-25 20:14:41 -0600 | Rating Details | |
| 2024-02-15 05:42:09 -0600 | Rating Details | |
| 2024-02-26 16:04:58 -0600 | Rating Details | |
| 2024-02-18 00:10:10 -0600 | Rating Details | |
| 2024-02-17 06:34:10 -0600 | Rating Details | |
| 2024-03-29 03:30:51 -0500 | Rating Details | |
| 2024-03-29 04:27:16 -0500 | Rating Details |